In addition, "Several case studies of people with Severe or Critical COVID-19... demonstrated that Leronlimab treatment was associated with a REDUCTION in elevated plasma IL-6 and CCL5, normalized CD4/CD8 ratios and was associated with HIGH rates of RECOVERY, suggesting Clinical Benefit."...I would guess We are beyond the duh? moment.